
In ottemperanza all'articolo 118 “autorizzazione della pubblicità presso il pubblico” del decreto legislativo 24 aprile 2006, numero 219
INDICATIONS
Treatment of simple conjunctivitis.
ACTIVE INGREDIENTS
100 ml contain. Active ingredients: Zinc sulfophenate 0.500 g, sodium sulfacetamide 3 g, naphazoline hydrochloride 0.005 g, lidocaine hydrochloride 0.750 g. Excipients with known effects: sodium merthiolate, para-hydroxy benzoic esters (methyl-p-hydroxybenzoate and propyl-p-hydroxybenzoate) For the complete list of excipients, see section 6.1.
EXCIPIENTS
Ammonium chloride, p-oxybenzoic esters, sodium merthiolate, purified water.
CONTRAINDICATIONS AND SIDE EFFECTS
Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1 towards the components of the product. Antiseptic Astringent Sedative is contraindicated in children under 6 years of age.
DOSAGE
Instill 1 drop, two or more times a day, into the inferior conjunctival fornix. After instillation, keep the eye closed for a few moments. Carefully follow the recommended doses. A higher dosage of the product, even if taken topically and for a short period of time, can give rise to serious systemic effects.
CONSERVATION
Store at a temperature not exceeding 30°C. The product should not be used beyond 30 days after first opening the container.
WARNINGS
Do not exceed the indicated doses. Do not administer for more than seven consecutive days without consulting your doctor. Pediatric population Do not administer to children under six years of age. If sensitization phenomena appear, discontinue treatment and institute suitable therapy. Astringent Sedative Antiseptic contains sodium merthiolate: it may cause allergic reactions.
INTERACTIONS
They are not known.
SIDE EFFECTS
No side effects related to the drug have been reported. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.
OVERDOSE
Given the poor systemic absorption, the effects of overdose are extremely rareri except in cases of accidental ingestion. If this happens, apply symptomatic therapy.
PREGNANCY AND BREASTFEEDING
pregnancy and breastfeeding. In women who are confirmed or presumed pregnant and during the breastfeeding period, the product should be administered in case of actual need, according to the doctor's opinion.
EFFECTS ON DRIVING ABILITY
The product does not interfere with the ability to drive or use machines.








